Boyer MJ - Search Results

1

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.

van Zandwijk N, Pavlakis N, Kao SC, Linton A, Boyer MJ, Clarke S, Huynh Y, Chrzanowska A, Fulham MJ, Bailey DL, Cooper WA, Kritharides L, Ridley L, Pattison ST, MacDiarmid J, Brahmbhatt H, Reid G. van Zandwijk N, et al. Among authors: boyer mj. Lancet Oncol. 2017 Oct;18(10):1386-1396. doi: 10.1016/S1470-2045(17)30621-6. Epub 2017 Sep 1. Lancet Oncol. 2017. PMID: 28870611 Clinical Trial.

2

Recent advances in managing non-small-cell lung cancer: 4. Chemotherapy of metastatic cancer.

Clarke SJ, Boyer MJ. Clarke SJ, et al. Among authors: boyer mj. Med J Aust. 1997 Jun 2;166(S1):S14-6. Med J Aust. 1997. PMID: 9201199

3

Non-surgical therapy for patients with advanced non-small cell lung cancer.

Clarke SJ, Boyer MJ. Clarke SJ, et al. Among authors: boyer mj. Respirology. 1998 Sep;3(3):175-82. doi: 10.1111/j.1440-1843.1998.tb00117.x. Respirology. 1998. PMID: 9767616 Review.

4

Evaluation of the role of positron emission tomography in oncology.

Viney RC, Fulham MJ, McCaughan BC, Boyer MJ, Hall JP. Viney RC, et al. Among authors: boyer mj. Med J Aust. 2000 May 1;172(9):459, 461. doi: 10.5694/j.1326-5377.2000.tb124059.x. Med J Aust. 2000. PMID: 10870544 No abstract available.

5

Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer.

Boyer MJ, Mitchell P, Goldstein D, Millward MJ, Olver IN, Clarke SJ, Richardson G, Davis I. Boyer MJ, et al. Lung Cancer. 2001 Apr;32(1):89-94. doi: 10.1016/s0169-5002(00)00207-5. Lung Cancer. 2001. PMID: 11282433 Clinical Trial.

6

Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer.

Clarke SJ, Abratt R, Goedhals L, Boyer MJ, Millward MJ, Ackland SP. Clarke SJ, et al. Among authors: boyer mj. Ann Oncol. 2002 May;13(5):737-41. doi: 10.1093/annonc/mdf115. Ann Oncol. 2002. PMID: 12075742 Free article. Clinical Trial.

7

Pemetrexed: single-agent and combination phase I study overview.

Boyer MJ, Rivory LP, Clarke SJ. Boyer MJ, et al. Semin Oncol. 2002 Dec;29(6 Suppl 18):18-23. doi: 10.1053/sonc.2002.37464. Semin Oncol. 2002. PMID: 12571806 Review.

8

Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients.

Millward MJ, Boyer MJ, Lehnert M, Clarke S, Rischin D, Goh BC, Wong J, McNeil E, Bishop JF. Millward MJ, et al. Among authors: boyer mj. Ann Oncol. 2003 Mar;14(3):449-54. doi: 10.1093/annonc/mdg118. Ann Oncol. 2003. PMID: 12598352 Free article. Clinical Trial.

9

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P. Vogelzang NJ, et al. J Clin Oncol. 2003 Jul 15;21(14):2636-44. doi: 10.1200/JCO.2003.11.136. J Clin Oncol. 2003. PMID: 12860938 Clinical Trial.

10

Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells.

Zhang M, Boyer M, Rivory L, Hong A, Clarke S, Stevens G, Fife K. Zhang M, et al. Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):353-60. doi: 10.1016/j.ijrobp.2003.09.032. Int J Radiat Oncol Biol Phys. 2004. PMID: 14751503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters